Other psychedelics
James Linden, Daniel Robin
Psychedelics as Psychiatric Medications March 1, 2023 DOI: 10.1093/med/9780192863607.003.0008 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Key findings | Lesser-known psychedelics are potent, poorly understood, and have minimal clinical data, but are of increasing interest for potential medical applications. |
Abstract
Abstract This chapter will detail some of the lesser-known psychedelics. While lesser known, some of these are arguably the most potent molecules, and one could argue these hold the most potential for medicine. We will go on a small journey into a lesser-understood corner of plant medicine and psychedelics. Many of the psychedelics discussed so far in this publication have well-elucidated and reasonably well-developed psychopharmacology. The lesser knowns are similarly less understood and have novel effects, the causes of which are still essentially baffling. In the great pursuit of psychedelic science there has been an increased interest to understand the potential of these lesser knowns, which will be overviewed here. There are also significantly fewer clinical data available for these, in fact, none in some cases, at least not of huge or encouraging impact to humanity thus far. It gives great pleasure to present five lesser knowns.
Citations in the library
Cites 7
- Prehistoric peyote use: alkaloid analysis and radiocarbon dating of archaeological specimens of Lophophora from Texas. Journal of Ethnopharmacology October 3, 2005
- The roles of 5-HT1A and 5-HT2 receptors in the effects of 5-MeO-DMT on locomotor activity and prepulse inhibition in rats. Psychopharmacology December 1, 2006
- A narrative synthesis of research with 5-MeO-DMT. Journal of Psychopharmacology March 1, 2022
- Acute Effects of the Novel Psychoactive Drug 2C-B on Emotions BioMed Research International 2015
- Serotonergic dorsal raphe neurons: changes in spontaneous neuronal activity and responsiveness to 5-MeODMT following long-term amphetamine administration. Neuroscience Letters August 14, 1989
and 2 more in the library